171 related articles for article (PubMed ID: 21546718)
21. P53 correlates positively with VEGF in preoperative sera of colorectal cancer patients.
Famulski W; Sulkowska M; Wincewicz A; Kedra B; Pawlak K; Zalewski B; Sulkowski S; Koda M; Baltaziak M
Neoplasma; 2006; 53(1):43-8. PubMed ID: 16416012
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-17 may be a valuable serum tumor marker in patients with colorectal carcinoma.
Radosavljevic G; Ljujic B; Jovanovic I; Srzentic Z; Pavlovic S; Zdravkovic N; Milovanovic M; Bankovic D; Knezevic M; Acimovic LJ; Arsenijevic N
Neoplasma; 2010; 57(2):135-44. PubMed ID: 20099977
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of thrombospondin-1 expression in relation to vascular endothelial growth factor and interleukin-10 expression at the deepest invasive tumor site of advanced colorectal carcinoma.
Kaio E; Tanaka S; Oka S; Hiyama T; Kitadai Y; Haruma K; Chayama K
Int J Oncol; 2003 Oct; 23(4):901-11. PubMed ID: 12963968
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of serum angiogenic activity in colorectal cancer patients.
Gonzalez FJ; Quesada AR; Sevilla I; Baca JJ; Medina MA; Amores J; Diaz JM; Rius-Diaz F; Marques E; Alba E
J Cell Mol Med; 2007; 11(1):120-8. PubMed ID: 17367506
[TBL] [Abstract][Full Text] [Related]
25. Identification of colorectal cancer metastasis markers by an angiogenesis-related cytokine-antibody array.
Abajo A; Bitarte N; Zarate R; Boni V; Lopez I; Gonzalez-Huarriz M; Rodriguez J; Bandres E; Garcia-Foncillas J
World J Gastroenterol; 2012 Feb; 18(7):637-45. PubMed ID: 22363134
[TBL] [Abstract][Full Text] [Related]
26. Preoperative serum vascular endothelial growth factor-a is a marker for subsequent recurrence in colorectal cancer patients.
Alabi AA; Suppiah A; Madden LA; Monson JR; Greenman J
Dis Colon Rectum; 2009 May; 52(5):993-9. PubMed ID: 19502868
[TBL] [Abstract][Full Text] [Related]
27. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer.
Miyazaki T; Okada N; Ishibashi K; Ogata K; Ohsawa T; Ishiguro T; Nakada H; Yokoyama M; Matsuki M; Kato H; Kuwano H; Ishida H
Jpn J Clin Oncol; 2008 Dec; 38(12):839-43. PubMed ID: 18923001
[TBL] [Abstract][Full Text] [Related]
29. Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients.
Benoy I; Salgado R; Colpaert C; Weytjens R; Vermeulen PB; Dirix LY
Clin Breast Cancer; 2002 Jan; 2(4):311-5. PubMed ID: 11899364
[TBL] [Abstract][Full Text] [Related]
30. Determination of IL-6, TNF-α and VEGF levels in the serums of patients with colorectal cancer.
Coşkun Ö; Öztopuz Ö; Özkan ÖF
Cell Mol Biol (Noisy-le-grand); 2017 May; 63(5):97-101. PubMed ID: 28719352
[TBL] [Abstract][Full Text] [Related]
31. Preoperative plasma vascular endothelial growth factor but not nitrite is a useful complementary tumor marker in patients with colorectal cancer.
Tsai WS; Changchien CR; Yeh CY; Chen JS; Tang R; Chiang JM; Hsieh PS; Fan CW; Wang JY
Dis Colon Rectum; 2006 Jun; 49(6):883-94. PubMed ID: 16741643
[TBL] [Abstract][Full Text] [Related]
32. Correlation of serum VEGF levels with clinical stage, therapy efficacy, tumor metastasis and patient survival in ovarian cancer.
Li L; Wang L; Zhang W; Tang B; Zhang J; Song H; Yao D; Tang Y; Chen X; Yang Z; Wang G; Li X; Zhao J; Ding H; Reed E; Li QQ
Anticancer Res; 2004; 24(3b):1973-9. PubMed ID: 15274387
[TBL] [Abstract][Full Text] [Related]
33. Pre-operative plasma levels of vascular endothelial growth factor A, C and D in patients with colorectal cancer.
Duff SE; Saunders M; McCredie V; Kumar S; O'Dwyer ST; Jayson GC
Clin Oncol (R Coll Radiol); 2005 Aug; 17(5):367-71. PubMed ID: 16097569
[TBL] [Abstract][Full Text] [Related]
34. The correlation between serum VEGF levels and known prognostic risk factors in colorectal carcinoma.
Beştaş R; Kaplan MA; Işikdoğan A
Hepatogastroenterology; 2014; 61(130):267-71. PubMed ID: 24901122
[TBL] [Abstract][Full Text] [Related]
35. Levels of VE-cadherin increase independently of VEGF in preoperative sera of patients with colorectal cancer.
Sulkowska M; Famulski W; Wincewicz A; Moniuszko T; Kedra B; Koda M; Zalewski B; Baltaziak M; Sulkowski S
Tumori; 2006; 92(1):67-71. PubMed ID: 16683386
[TBL] [Abstract][Full Text] [Related]
36. [Clinical significance of VEGF levels in serums of colorectal cancer patients at stage IV].
Huang N; Yang L; Cao MR; Su N; Chen JZ; Lü CW; Liao WJ; Luo RC
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Feb; 29(2):278-9. PubMed ID: 19246299
[TBL] [Abstract][Full Text] [Related]
37. Preoperative serum vascular endothelial growth factor is not a marker for subsequent recurrence during long-term follow-up of colorectal cancer patients.
Roumen RM; Slooter GD; Croiset van Uchelen FA; Huib LV
Dis Colon Rectum; 2005 May; 48(5):1070-5. PubMed ID: 15785896
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of serum Tie-2 and vascular endothelial growth factor levels in cancer patients.
Seker MM; Sancaktar E; Acibucu DO; Filiz AK; Deveci K; Bahceci A; Kacan T; Babacan N; Yuce S
Eur Rev Med Pharmacol Sci; 2013 Nov; 17(21):2929-32. PubMed ID: 24254563
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of serum vascular endothelial growth factor and complement 3a levels in patients with colorectal cancer in southern Iran.
Mehrabani D; Shamsdin SA; Dehghan A; Safarpour A
Asian Pac J Cancer Prev; 2014; 15(22):9713-7. PubMed ID: 25520093
[TBL] [Abstract][Full Text] [Related]
40. Elevated IL-8 levels in the drainage vein of resectable Dukes' C colorectal cancer indicate high risk for developing hepatic metastasis.
Haraguchi M; Komuta K; Akashi A; Matsuzaki S; Furui J; Kanematsu T
Oncol Rep; 2002; 9(1):159-65. PubMed ID: 11748475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
